Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
Sandborn WJ, Sands BE, Wolf DC, Valentine JF, Safdi M, Katz S, Isaacs KL, Wruble LD, Katz J, Present DH, Loftus EV Jr, Graeme-Cook F, Odenheimer DJ, Hanauer SB. Sandborn WJ, et al. Among authors: katz j, katz s. Aliment Pharmacol Ther. 2003 Jun 1;17(11):1355-64. doi: 10.1046/j.1365-2036.2003.01589.x. Aliment Pharmacol Ther. 2003. PMID: 12786629 Clinical Trial.
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.
Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA, Lashner B, Present DH, Chuai S, Ellenberg JH, Nessel L, Wu GD; Rosiglitazone for Ulcerative Colitis Study Group. Lewis JD, et al. Among authors: katz ja. Gastroenterology. 2008 Mar;134(3):688-95. doi: 10.1053/j.gastro.2007.12.012. Epub 2007 Dec 7. Gastroenterology. 2008. PMID: 18325386 Free PMC article. Clinical Trial.
Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody.
Ramasamy K, Vij R, Kuter D, Cella D, Durie BGM, Abonour R, Rifkin RM, Ailawadhi S, Lee HC, Cowan AJ, Ho C, Dhanasiri S, Fish S, Yu E, Dhamane AD, Fang J, Marshall TS, Samuel A, Liu L, Katz J, Gu T, Jagannath S. Ramasamy K, et al. Among authors: katz j. Clin Lymphoma Myeloma Leuk. 2024 Dec 6:S2152-2650(24)02441-8. doi: 10.1016/j.clml.2024.12.002. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39799046 Free article.
Sewing the SEAMs: Surgical Education in the Art Museum.
Cohen SM, DiGiovanni-Evans B, Ganske IM, Katz JT, Kent TS. Cohen SM, et al. Among authors: katz jt. J Surg Educ. 2025 Jan 10;82(3):103401. doi: 10.1016/j.jsurg.2024.103401. Online ahead of print. J Surg Educ. 2025. PMID: 39798165
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial.
Gustafsson F, Uriel N, Netuka I, Katz JN, Pagani FD, Connors JM, Jorde UP, Zimpfer D, Pya Y, Conway J, Anyanwu A, Scandroglio AM, Sulemanjee N, Atluri P, Keebler M, Selzman CH, Alexis JD, Hayward C, Henderson J, Dirckx N, Gazzola C, Mehra MR; ARIES Investigators. Gustafsson F, et al. Among authors: katz jn. JAMA Cardiol. 2025 Jan 8. doi: 10.1001/jamacardio.2024.4849. Online ahead of print. JAMA Cardiol. 2025. PMID: 39774588
Early Evolution of SCAI Shock Stage and In-Hospital Mortality in the Cardiovascular Intensive Care Unit Population: From the Critical Care Cardiology Trials Network (CCCTN).
Skove S, Berg DD, Bohula EA, Guo J, Alfonso CE, Barsness GW, Burke JA, Chonde MD, Jentzer JC, Katz JN, Kontos MC, Kwon Y, Lawler PR, Liu S, Miller PE, O'Brien CG, Papolos AI, Proudfoot AG, Sidhu K, Sinha SS, Sridharan L, Teuteberg JJ, van Diepen S, Zakaria S, Morrow DA, Shah KS. Skove S, et al. Among authors: katz jn. Circ Heart Fail. 2025 Jan 8:e012109. doi: 10.1161/CIRCHEARTFAILURE.124.012109. Online ahead of print. Circ Heart Fail. 2025. PMID: 39772549 No abstract available.
5,226 results